You have 9 free searches left this month | to do more
Showing 1 - 25 of
7,322 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
B
Withdrawn
  • COVID-19
  • BRII-196 and BRII-198
  • Placebo
  • Hong Kong, China
    Investigative Site 1
2022-03-01
Mar 1, 2022
B
Completed
  • COVID-19
  • BRII-196 and BRII-198
  • Placebo
  • Beijing, Beijing, China
    Investigative Site
2022-03-01
Mar 1, 2022
B
Completed
  • COVID-19
  • BRII-196 and BRII-198
  • Placebo
  • Beijing, Beijing, China
  • +5 more
2022-03-01
Mar 1, 2022
L
Terminated
  • Ovarian Cancer
  • Monoclonal antibody hu3S193
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2021-07-20
Jul 20, 2021
F
Not yet recruiting
  • Solid Tumor, Adult
  • (no location specified)
2021-10-01
Oct 1, 2021
M
Completed
  • Neuroblastoma
  • beta-glucan
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2022-03-04
Mar 4, 2022
G
Active, not recruiting
  • Metastatic Colon Cancer
  • Alcoy, Alicante, Spain
  • +47 more
2022-03-15
Mar 15, 2022
M
Recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +10 more
  • Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-30
Mar 30, 2022
M
Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +9 more
  • DNA analysis
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-10-28
Oct 28, 2021
L
Completed
  • Ovarian Cancer
  • 90Y-hu3S193
  • 111In-hu3S193
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2021-11-23
Nov 23, 2021
E
Active, not recruiting
  • Colon Carcinoma Metastatic in the Liver
  • +13 more
  • Anti-SEMA4D Monoclonal Antibody VX15/2503
  • +3 more
  • Atlanta, Georgia
  • +3 more
2021-12-15
Dec 15, 2021
Z
Not yet recruiting
  • Hematological Malignancies
  • NK cells/Combined Monoclonal Antibodies
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
2020-12-08
Dec 8, 2020
L
Terminated
  • Colorectal Cancer
  • monoclonal antibody hu3S193
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2021-07-15
Jul 15, 2021
M
Recruiting
  • CD30-Positive Neoplastic Cells Present
  • Malignant Mesothelioma
  • Brentuximab Vedotin
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
2022-01-03
Jan 3, 2022
M
Recruiting
  • Adult Acute Lymphoblastic Leukemia in Complete Remission
  • +3 more
  • Blinatumomab
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
2021-09-22
Sep 22, 2021
N
Completed
  • HIV Infections
  • F105 Monoclonal Antibody (Human)
  • Boston, Massachusetts
    Beth Israel Deaconess Med. Ctr., ACTG CRS
2021-10-28
Oct 28, 2021
W
Active, not recruiting
  • Human Papillomavirus Infection
  • +11 more
  • Durvalumab
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
2021-12-17
Dec 17, 2021
M
Completed
  • Neuroblastoma
  • anti-GD2 murine IgG3 monoclonal antibody 3F8
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2021-01-26
Jan 26, 2021
J
Terminated
  • Metastatic Melanoma
  • +5 more
  • Anti-SEMA4D Monoclonal Antibody VX15/2503
  • +4 more
  • Los Angeles, California
  • +1 more
2021-04-01
Apr 1, 2021
L
Completed
  • Lung Cancer
  • monoclonal antibody hu3S193
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2022-02-07
Feb 7, 2022
Y
Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +2 more
  • Iodine I 131 MOAB 8H9
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2022-02-07
Feb 7, 2022
F
Terminated
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +32 more
  • indium In 111 anti-CD45 monoclonal antibody BC8
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
2021-03-07
Mar 7, 2021
B
Enrolling by invitation
  • PTLD
  • +2 more
  • low-dose CD20 monoclonal antibody injection
  • Beijing, Beijing, China
    Beijing Friendship Hospital
2022-02-24
Feb 24, 2022
U
Recruiting
  • Non-Hodgkin Lymphoma
  • +7 more
  • Mosunetuzumab
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-28
Mar 28, 2022